Federal contract award

75N93020F00001

THIS TASK ORDER IS TO MANUFACTURE STERILE BULK PRODUCT TLC-ART101 (2 L) IN FULL COMPLIANCE WITH CGMP REGULATIONS. TLC-ART 101 (TARGETED LONG-ACTING COMBINATION ANTI-RETROVIRAL THERAPY 101) IS A PREPARATION OF THREE ANTIRETROVIRALS LOPINAVIR, RITONAVI

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541712
PSCAN81 — AIDS RESEARCH - BASIC RESEARCH
Parent award / vehicleHHSN272201400006I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$1.1M
Current contract value$1.1M
Potential contract value / ceiling$1.1M
Start dateJul 15, 2020
Current end dateDec 24, 2021
Potential end dateDec 24, 2021
Latest award activityJul 8, 2021
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 8, 2021P00001$294.8KTHIS TASK ORDER IS TO MANUFACTURE STERILE BULK PRODUCT TLC-ART101 (2 L) IN FULL COMPLIANCE WITH CGMP REGULATIONS. TLC-ART 101 (TARGETED LONG-ACTING COMBINATION ANTI-RETROVIRAL THERAPY 101) IS A PREPARATION OF THREE ANTIRETROVIRALS LOPINAVIR, RITONAVI
Jul 7, 20200$785.6KTHIS TASK ORDER IS TO MANUFACTURE STERILE BULK PRODUCT TLC-ART101 (2 L) IN FULL COMPLIANCE WITH CGMP REGULATIONS. TLC-ART 101 (TARGETED LONG-ACTING COMBINATION ANTI-RETROVIRAL THERAPY 101) IS A PREPARATION OF THREE ANTIRETROVIRALS LOPINAVIR, RITONAVI

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.